Form 8-K - Current report:
SEC Accession No. 0001628280-26-011941
Filing Date
2026-02-26
Accepted
2026-02-26 06:04:15
Documents
14
Period of Report
2026-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20260226.htm   iXBRL 8-K 33878
2 EX-99.1 exhibit991-q42025earningsr.htm EX-99.1 449598
6 bgi2404beoneprimarylogorgba.jpg GRAPHIC 1350567
  Complete submission text file 0001628280-26-011941.txt   2491810

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20260226.xsd EX-101.SCH 1867
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20260226_lab.xml EX-101.LAB 22720
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20260226_pre.xml EX-101.PRE 13107
16 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20260226_htm.xml XML 2863
Mailing Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051
Business Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051 41-616851900
BeOne Medicines Ltd. (Filer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 26681459
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)